Sign in
Enrolling by invitationNo phase

Preparation of IPSC for Cell Gene Editing for the Treatment of AATD

Key facts

Who runs it
Fondazione IRCCS Policlinico San Matteo di Pavia
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
3 people, planned
Started
15 Jan 2025
Planned end
28 Feb 2026
Type of study
Interventional
Treatments tested
  • iPSC generation
Record updated
24 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • age ≥ 18 years at the time of signing the ICF
  • diagnosis of severe AATD (2 pathological variants)

Who cannot take part

  • subject under augmentation therapy
  • incapability to give informed consent

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Alpha 1-antitrypsin (AAT) deficiency is a genetic condition that leads to lung and/or liver diseases; current treatment of weekly augmentation of AAT addresses only lung diseases with moderate efficacy. Novel treatments based on gene editing can restore physiological levels of AAT and address lung and liver disease.

Read full original descriptionShow less

The aim is to generate induced pluripotent stem cells (iPSC) from blood and urine of patients with different severe Alpha1-antitrypsin deficiency (AATD) genotypes. Further, the iPSC will be differentiated into hepatocytes (iHep). Since hepatocytes are the main producers of AAT, the iHep will be used to test different approaches of gene editing to correct various mutations. Gene editing will be conducted at University of Bern (Switzerland)

The group in the trial

  • severe AATD patientsOther group

    blood samples from severe AATD patients to obtain iPSC cells

    Treatment: iPSC generation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Preparation of Large-scale Patient-specific Induced Pluripotent Stem Cells (iPSC) Library for Cell Gene Editing for the Treatment of Alpha1-antitrypsin Deficiency
Record updated
24 March 2025